Startseite Herzlungenzentrum Ebreichsdorf - Dr. Haas & Dr. Stiebellehner: Internist Wien, Kardiologe, Pulmologe, Lungenfacharzt

STARTSEITE  

KONTAKT/ANMELDUNG  

Kardiologe, Internist
Univ. Doz. Dr. Martin Haas

Medizinische Leistungen

Zur Person

Publikationsliste

Terminvereinbarung

 

Lungenfacharzt, Internist
Univ. Doz. Dr. Leopold Stiebellehner

Medizinische Leistungen

Ordination 1190 Wien

Zur Person

Publikationsliste

Zum Nachlesen
 

LINKS  

IMPRESSUM  

Startseite Herzlungenzentrum Ebreichsdorf - Dr. Haas & Dr. Stiebellehner: Internist Wien, Kardiologe, Pulmologe, Lungenfacharzt

Inhalt: Herz-Lungen-Zentrum Ebreichsdorf, Dr. Martin Haas, Dr. Leopold Stiebellehner, Internist Wien, Pulmologe Wien, Kardiologe Wien, Pulmologie, Lungenfacharzt, Kardiologie, Innere Medizin, Herzinfarkt, Bluthochdruck, Atemnot, Asthma, Schlafapnoe

Dr. Leopold StiebellehnerPublikationsliste

Univ. Doz. Dr. Leopold Stiebellehner


  1. Stiebellehner L, Belknap JK, Ensley B, Tucker A, Orton EC, Reeves JT, Stenmark KR. Lung endothelial cell proliferation in normal and pulmonary hypertensive neonatal calves.
    Am J Physiol Lung Cell Mol Physiol 1998; 275(3 Pt 1): L593-600.

  2. Stiebellehner L, Quittan M, End A, Wieselthaler G, Klepetko W, Haber P, Burghuber OC. Aerobic endurance training program improves exercise performance in lung transplant recipients.
    Chest 1998 Apr; 113(4): 906-12.

  3. Stiebellehner L, Nikfardjan M, Diem K, Atteneder M, Stulnig T, Priglinger U, Gottsauner-Wolf M, Huber K. Manuelle Kompression versus mechanischer Kompressionshilfe (FemoStop®) nach diagnostischer Koronarangiographie mit/ohne Intervention.
    Wien Klin Wochenschr 2002; 114/19-20: 847-852

  4. Stiebellehner L, Frid M, Reeves JT, Low RB, Gnanasekharan MG, Stenmark KR. The bovine distal pulmonary arterial media is comprised of a uniform population of well-differentiated smooth muscle cells with low proliferative capabilities.
    Am J Physiol Lung Cell Mol Physiol 2003; 285: L819 – L828

  5. Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, Block LH. Long-term treatment with oral Sildenafil (Viagra®) in addition to continuous IV Epoprostenol (Flolan®) in patients with pulmonary arterial hypertension.
    Chest 2003; 123: 1293 - 1295
    (Editorial: Sildenafil for Pulmonary Arterial Hypertension – Exciting, but protection required. S. Mehta, Chest 2003; 123: 989 – 991)

  6. Huppmann M, Schreiber W, Moder G, Fugger B, Kapfhammer G, Stiebellehner L. Empfehlungen zur ambulante Polygraphie der Österreichischen Gesellschaft für Pneumologie. Wiener Klinische Wochenschrift 2007

  7. Mueller-Mang C, Stiebellehner L, Schmid K, Bankier A. Idiopathic interstital pneumonias. From classification to diagnostic work-up. Radiologe 2007; 47: 384-92

  8. Mueller-Mang C, Grosse C, Schmid K, Stiebellehner L, Bankier AA. What every radiologist should know about idiopathic interstitial pneumonias. Radigraphics 2007; 27 (3): 595-615

  9. Stadler A, Stiebellehner L, Jakob PM, Arnold JF, Bankier AA. T1 maps and O(2)-enhanced MRT of the diseased lung : Emphysema, fibrosis, mucoviscidosis.
    Radiologe. 2006 Apr;46(4):282-9

  10. Scharitzer M, Dekan G, Stiebellehner L, Bankier AA. An 83-year-old female with worsening dyspnoea and bleeding from a cavernostomy.
    Eur Respir J. 2006 Jan;27(1):233-7

  11. Schenk P, Stiebellehner L, Burghuber OC, Kneussl M, Lang IM; Austrian Society for Pneumology; Austrian Society for Cardiology. Examination of pulmonary circulation using right heart catheterization. Position paper of the Cardiopulmonary Task Force of the Austrian Society for Pneumology and the Austrian Society for Cardiology
    Wien Klin Wochenschr. 2005 Sep;117(18):651-62.

  12. Petkov V, Mosgöller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH. Vasactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.
    JCI 2003; 111: 1339 – 1346

  13. Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, Germann P, Block LH. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD.
    Thorax 2003; 58: 289-293
    (Editorial: Pulmonary hypertension in patients with COPD: NO treatment? Pepke-Zaba J, Morell NW. Thorax 2003: 58(4); 283-4.)

  14. Schenk P, Madl C, Kramer L, Zauner C, Funk G, Lang I, Stiebellehner L, Petkov V, Vonbank K, Ziesche R, Kneussl M, Ratheiser K. Acute vasodilator testing in primary and secondary pulmonary hypertension.
    Wien Klin Wochenschr 2001; 113/13-14: 496-503.

  15. Ziesche R, Petkov V, Wittmann K, Kopatschka J, Stiebellehner L, Schenk P, Germann P, Röder G, Ullrich R, Block LH. Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.
    Heart 2000; 83: 406-409.

  16. Petkov V, Ziesche R, Mosgoeller W, Schenk P, Vonbank K, Stiebellehner L, Raderer M, Brunner C, Kneussl M, Block LH. Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.
    Thorax 2001 Sep; 56(9): 734-6

  17. Stiebellehner L, Petkov V, Schenk P, Vonbank K, Ziesche R, Block LH. Die pulmonal-arterielle Hypertension – Klinik, Diagnostik, Therapie.
    J Hypertonie 2002; 1: 7 - 14

Webdesign by berghWerk